Stoke Therapeutics Statistics
NASDAQ: STOKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
24.29-0.08 (-0.33%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Stoke Therapeutics by the numbers
Stoke Therapeutics has a market capitalization of $1.57 billion based on 64.53M shares outstanding. With trailing EPS of $-3.38, Stoke Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.3% below its 50-day average and 23.1% below its 200-day average.
Average daily trading volume is 855.44K shares, or about $20.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
STOK valuation vs. peer median
| Metric | STOK | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.57B | $1.58B | -1% |
| Avg. volume | 855.44K | 1.18M | -28% |
Peer median across 8 companies: ETON, OCUL, QURE, PAHC, CMPS, INVA, SNDX, ANIP.
Valuation
- Market cap
- $1.57B
- EPS (TTM)
- $-3.38
- Shares outstanding
- 64.53M
Price and trading
- Previous close
- 24.37
- Open
- 24.13
- Day range
- 23.95 – 24.70
- 52-week range
- 20.32 – 40.22
- 52-week change
- -11.06%
- Beta
- —
- Volume
- 510.49K
- Average volume
- 855.44K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 1.57B
- Forward Pe
- -6.91
- Eps
- -3.38
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.22
- Week52 Low
- 20.32
- Avg Volume
- 855.44K
- Shares Outstanding
- 64.53M
- Ma50
- 29.73
- Ma200
- 31.57
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -39.61%
- Pct From52w Low
- 19.54%